The dual c-Met/VEGFR2 inhibitor foretinib augments chemotherapy response in preclinical models of gastric cancer

被引：1
|
作者：
Awasthi, Niranjan [1 ]
Grojean, Meghan [1 ]
Monahan, Sheena [1 ]
Hassan, Sazzad [1 ]
von Holzen, Urs [1 ]
Schwarz, Margaret A. [1 ]
Schwarz, Roderich E. [1 ]
机构：
[1] Indiana Univ Sch Med, South Bend, IN USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-5807
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5807
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis
    Zillhardt, Marion
    Park, Sun-Mi
    Romero, Iris L.
    Sawada, Kenjiro
    Montag, Anthony
    Krausz, Thomas
    Yamada, S. Diane
    Peter, Marcus E.
    Lengyel, Ernst
    CLINICAL CANCER RESEARCH, 2011, 17 (12) : 4042 - 4051
  • [22] Preclinical Evaluation of a Novel c-Met Inhibitor in a Gastric Cancer Xenograft Model Using Small Animal PET
    Wiehr, Stefan
    von Ahsen, Oliver
    Roese, Lars
    Mueller, Andre
    Mannheim, Julia G.
    Honndorf, Valerie
    Kukuk, Damaris
    Reischl, Gerald
    Pichler, Bernd J.
    MOLECULAR IMAGING AND BIOLOGY, 2013, 15 (02) : 203 - 211
  • [23] Preclinical Evaluation of a Novel c-Met Inhibitor in a Gastric Cancer Xenograft Model Using Small Animal PET
    Stefan Wiehr
    Oliver von Ahsen
    Lars Röse
    Andre Mueller
    Julia G. Mannheim
    Valerie Honndorf
    Damaris Kukuk
    Gerald Reischl
    Bernd J. Pichler
    Molecular Imaging and Biology, 2013, 15 : 203 - 211
  • [24] Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models
    Gavine, Paul R.
    Ren, Yongxin
    Han, Lu
    Lu, Jing
    Fan, Shiming
    Zhang, Wei
    Xu, Wen
    Liu, Yuan Jie
    Zhang, Tianwei
    Fu, Haihua
    Yu, Yongjuan
    Wang, Huiying
    Xu, Shirlian
    Zhou, Feng
    Su, Xinying
    Yin, XiaoLu
    Xie, Liang
    Wang, Linfang
    Qing, Weiguo
    Jiao, Longxian
    Su, Weiguo
    Wang, Q. May
    MOLECULAR ONCOLOGY, 2015, 9 (01) : 323 - 333
  • [25] Foretinib Inhibits Cancer Sternness and Gastric Cancer Cell Proliferation by Decreasing CD44 and c-MET Signaling
    Sohn, Sung-Hwa
    Kim, Bohyun
    Sul, Hee Jung
    Choi, Bo Youn
    Kim, Hyeong Su
    Zang, Dae Young
    ONCOTARGETS AND THERAPY, 2020, 13 : 1027 - 1035
  • [26] Dual blockade of MET and VEGFR2 signaling pathways as a potential therapeutic maneuver for peritoneal carcinomatosis in scirrhous gastric cancer
    Kasai, Suguru
    Kuwayama, Naomi
    Motoo, Yoshiharu
    Kawashima, Atsuhiro
    Matsumoto, Kunio
    Yano, Seiji
    Matsushima, Kouji
    Yasumoto, Kazuo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 600 : 80 - 86
  • [27] Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
    Shah, Manish A.
    Wainberg, Zev A.
    Catenacci, Daniel V. T.
    Hochster, Howard S.
    Ford, James
    Kunz, Pamela
    Lee, Fa-Chyi
    Kallender, Howard
    Cecchi, Fabiola
    Rabe, Daniel C.
    Keer, Harold
    Martin, Anne-Marie
    Liu, Yuan
    Gagnon, Robert
    Bonate, Peter
    Liu, Li
    Gilmer, Tona
    Bottaro, Donald P.
    PLOS ONE, 2013, 8 (03):
  • [28] Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells
    Park, Chi Hoon
    Cho, Sung Yun
    Ha, Jae Du
    Jung, Heejung
    Kim, Hyung Rae
    Lee, Chong Ock
    Jang, In-Young
    Chae, Chong Hak
    Lee, Heung Kyoung
    Choi, Sang Un
    BMC CANCER, 2016, 16
  • [29] Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells
    Chi Hoon Park
    Sung Yun Cho
    Jae Du Ha
    Heejung Jung
    Hyung Rae Kim
    Chong Ock Lee
    In-Young Jang
    Chong Hak Chae
    Heung Kyoung Lee
    Sang Un Choi
    BMC Cancer, 16
  • [30] Trametinib, a MEK inhibitor, augments nab-paclitaxel based chemotherapy response in preclinical models of pancreatic cancer
    Awasthi, Niranjan
    Monahan, Sheena
    Stefaniak, Alexis
    Schwarz, Margaret A.
    Schwarz, Roderich E.
    CANCER RESEARCH, 2017, 77
12345